证券代码：301565 证券简称：中仑新材 公告编号：2024-026 中仑新材料股份有限公司 第二届董事会第五次会议决议公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、 误导性陈述或重大遗漏。 一、董事会会议召开情况 具体内容详见同日披露于巨潮资讯网（www.cninfo.com.cn）的《2024 年第 三季度报告》。 本议案已经第二届董事会审计委员会 2024 年第五次会议审议通过。 表决结果：同意 7 票，反对 0 票，弃权 0 票。 2、逐项审议通过《关于制定修订公司治理制度的议案》 2024 年 10 月 24 日，中仑新材料股份有限公司（以下简称"公司"）第二 届董事会第五次会议在公司会议室以现场及通讯会议的方式召开，会议通知于 2024 年 10 月 21 日以电话或邮件的形式发出。会议应出席董事 7 人，实际出席 董事 7 人，会议由董事长杨清金先生主持，部分监事及高级管理人员列席会议。 本次会议的召开符合相关法律法规和《公司章程》规定。 二、董事会会议审议情况 1、审议通过《关于 2024 年第三季度报告的议案》 公司《2024 年第三季度报告》的编制和审核程 ...

证券代码：301565 证券简称：中仑新材 公告编号：2024-027 中仑新材料股份有限公司 第二届监事会第六次会议决议公告 本公司及监事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、 误导性陈述或重大遗漏。 一、监事会会议召开情况 表决结果：同意 3 票，反对 0 票，弃权 0 票。 2、审议《关于调整部分募集资金投资项目计划进度的议案》 经审核，监事会认为，公司本次调整募投项目"高性能膜材项目-高功能性 BOPA 膜材产业化项目"及"高性能聚酰胺材料产业化项目"的计划进度，是公 司根据募投项目实际情况做出的审慎决定，不存在变相改变募集资金投向和损害 公司及股东利益的情形。本次调整募投项目进度是为了更好地提高募投项目建设 质量，有利于募集资金投资项目的合理推进，不会对公司正常经营造成重大不利 影响，符合公司长期发展规划。 具体内容详见同日披露于巨潮资讯网（www.cninfo.com.cn）的《关于调整 部分募集资金投资项目计划进度的公告》。 2024 年 10 月 24 日，中仑新材料股份有限公司（以下简称"公司"）第二 届监事会第六次会议在公司会议室以现场会议的方式召开，会议通知于 20 ...

Revenue and Profit - Revenue for Q3 2024 reached ¥625,752,255.17, an increase of 2.72% year-over-year, while year-to-date revenue totaled ¥1,811,745,210.23, up 6.92% compared to the same period last year[2]. - Net profit attributable to shareholders for Q3 2024 was ¥15,085,403.49, a decrease of 67.54% year-over-year, with year-to-date net profit at ¥115,239,111.47, down 29.41%[2]. - Basic earnings per share for Q3 2024 was ¥0.04, reflecting a decline of 70.74% compared to the same quarter last year, while year-to-date earnings per share was ¥0.32, down 33.33%[2]. - Net profit for Q3 2024 was ¥115,239,111.47, compared to ¥163,258,389.38 in Q3 2023, reflecting a decrease of approximately 29.4%[13]. - The total comprehensive income attributable to the parent company for Q3 2024 is CNY 116,424,458.96, down from CNY 163,258,389.38 year-on-year, indicating a decrease of about 28.7%[14]. - Basic and diluted earnings per share for Q3 2024 are both CNY 0.32, compared to CNY 0.48 in the previous year, reflecting a decline of 33.3%[14]. Assets and Equity - Total assets as of the end of Q3 2024 amounted to ¥3,616,288,184.58, representing a 26.63% increase from the end of the previous year[2]. - Shareholders' equity attributable to the parent company reached ¥2,351,130,478.45, a significant increase of 46.96% compared to the end of the previous year[2]. - The company's total assets as of Q3 2024 amounted to ¥3,616,288,184.58, an increase from ¥2,855,735,925.35 year-over-year[11]. - The total equity attributable to shareholders increased to ¥2,351,130,478.45 from ¥1,599,867,106.73 year-over-year, reflecting a growth of about 46.9%[11]. Cash Flow - The net cash flow from operating activities for the year-to-date period was ¥437,067,633.71, an increase of 39.54% year-over-year[2]. - The company reported a significant increase in cash and cash equivalents, up 40.87% to ¥636,654,652.35, primarily due to proceeds from the initial public offering[5]. - Net cash flow from operating activities increased by 39.54% to ¥437,067,633.71, attributed to higher sales collections and increased export tax refunds[6]. - Net cash flow from investing activities decreased significantly by 380.65% to -¥515,152,837.79, mainly due to the use of temporarily idle funds for purchasing financial products[6]. - Net cash flow from financing activities increased by 198.48% to ¥258,583,327.11, primarily from funds raised through the IPO[6]. - Cash inflow from operating activities for Q3 2024 is CNY 1,943,334,702.85, an increase from CNY 1,819,126,593.64 in the same period last year, marking a growth of approximately 6.8%[16]. - The net cash flow from operating activities for Q3 2024 is CNY 437,067,633.71, up from CNY 313,209,350.47 year-on-year, representing an increase of about 39.7%[16]. - The net cash flow from investing activities for Q3 2024 is -CNY 515,152,837.79, compared to -CNY 107,179,066.89 in the previous year, indicating a larger outflow[16]. - The net cash flow from financing activities for Q3 2024 is CNY 258,583,327.11, a significant improvement from -CNY 262,576,034.06 in the same period last year[17]. - The cash and cash equivalents at the end of Q3 2024 amount to CNY 424,644,076.90, an increase from CNY 253,198,623.12 at the end of the previous year, reflecting a growth of approximately 67.6%[17]. - The company received tax refunds of CNY 90,511,477.29 in Q3 2024, compared to CNY 26,831,313.50 in the same period last year, indicating a significant increase of about 237.5%[16]. - The total cash inflow from financing activities for Q3 2024 is CNY 982,343,803.94, compared to CNY 249,195,203.11 in the previous year, showing a substantial increase of approximately 294.5%[17]. Inventory and Expenses - Inventory levels rose by 62.56% to ¥413,932,384.51, attributed to increased production and higher stock levels[5]. - Research and development expenses for Q3 2024 were ¥55,946,663.61, up from ¥52,528,937.79 in the same quarter last year, indicating a focus on innovation[13]. - The company reported a decrease in income tax expenses by 50.14% to ¥11,624,637.75, mainly due to a reduction in total profit[6]. - The company reported a decrease in tax expenses to ¥11,624,637.75 from ¥23,314,747.22 in the previous year, a reduction of approximately 50%[13]. - Total operating costs for Q3 2024 were ¥1,693,877,445.38, up from ¥1,504,316,402.26 in the previous year, indicating a rise of about 12.6%[13].

证券代码：301565 证券简称：中仑新材 公告编号：2024-030 中仑新材料股份有限公司 关于部分募集资金专户完成销户的公告 | 开户主体 | 开户行 | 账号 | 募集资金用途 | 账户状 | | --- | --- | --- | --- | --- | | | | | | 态 | | 中仑新材料股份有 | | 4100023819200398843 | | | | 限公司 | 中国工商银 | | 高性能膜材项 | | | 厦门长塑实业有限 | 行股份有限 | 4100023819200393384 | 目-高功能性 | 正常使 | | 公司 | 公司厦门东 | | BOPA 膜材产业 | 用 | | 福建长塑实业有限 | 区支行 | | 化项目 | | | 公司 | | 4100023819200395463 | | | | 中仑新材料股份有 | | 129480100100434414 | | | | 限公司 | 兴业银行股 | | 高性能膜材项 | | | 厦门长塑实业有限 | 份有限公司 | | 目-新型生物 | 本次销 | | | | 129480100100434653 | | | | ...

中仑新材料股份有限公司 内幕信息知情人登记管理制度 第一章 总 则 第一条 为进一步规范中仑新材料股份有限公司（以下简称"公司"）内 幕信息管理行为，加强公司内幕信息保密工作，维护公司信息披露的公开、公 平、公正原则，保护广大投资者的合法权益，根据《中华人民共和国公司法》 （以下简称"《公司法》"）《中华人民共和国证券法》（以下简称"《证券 法》"）《上市公司信息披露管理办法》《深圳证券交易所创业板股票上市规 则》（以下简称"《股票上市规则》"）《上市公司监管指引第 5 号——上市 公司内幕信息知情人登记管理制度》等有关法律法规及《中仑新材料股份有限 公司章程》（以下简称"《公司章程》"）的有关规定，结合公司的实际情 况，特制定本制度。 第二条 董事会是公司内幕信息的管理机构，董事会秘书为公司内幕信息 保密工作负责人，证券事务中心为公司内幕信息的监督、管理、登记、披露及备 案的日常工作部门。监事会对本制度的实施执行情况进行监督。 第三条 未经公司董事会或董事会秘书批准同意，公司任何部门和个人不 得自行向外界泄露、报道、传送涉及公司内幕信息的有关内容。公司依法报送 或披露的信息，严格按照证券监管有关规定进行。对 ...

证券代码：301565 证券简称：中仑新材 公告编号：2024-029 （一）募集资金投资项目基本情况 中仑新材料股份有限公司 关于调整部分募集资金投资项目计划进度的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、 误导性陈述或重大遗漏。 中仑新材料股份有限公司（以下简称"公司"、"中仑新材"）于 2024 年 10 月 24 日召开了第二届董事会独立董事专门会议 2024 年第三次会议、第二届 董事会第五次会议、第二届监事会第六次会议，分别审议通过了《关于调整部分 募集资金投资项目计划进度的议案》，同意公司将募集资金投资项目"高性能膜 材项目-高功能性 BOPA 膜材产业化项目"及"高性能聚酰胺材料产业化项目"的 预计完成日期分别调整至 2026 年 6 月 30 日及 2027 年 6 月 30 日。此次调整不 涉及募集资金用途变更，无需提交公司股东大会审议。公司保荐人海通证券股份 有限公司对本事项出具了核查意见。现将有关事宜公告如下： 一、募集资金基本情况 经中国证券监督管理委员会《关于同意中仑新材料股份有限公司首次公开发 行股票注册的批复》（证监许可〔2024)112 号 ...

中仑新材料股份有限公司 信息披露管理制度 第一章 总 则 第一条 为加强中仑新材料股份有限公司（以下简称"公司"）的信息披露事务管 理，规范信息披露行为，保证披露信息的真实性、准确性、完整性、及时性、公平 性，保护投资者合法权益，根据《中华人民共和国公司法》《中华人民共和国证券 法》《上市公司信息披露管理办法》《深圳证券交易所创业板股票上市规则》（以 下简称"《上市规则》"）《深圳证券交易所上市公司自律监管指引第2号—创业 板上市公司规范运作》《深圳证券交易所上市公司自律监管指引第5号—信息披露 事务管理》等法律、法规、部门规章及《中仑新材料股份有限公司章程》（以下简 称"《公司章程》"）的相关规定，结合公司实际情况，制定本制度。 第二条 本制度适用于以下人员和机构： （一）公司董事和董事会； （五）公司总部各部门以及各子公司、分公司的负责人； （六）公司控股股东和单独或合计持有公司5%以上股份的股东； （七）根据《上市规则》及其他法律、法规、规范性文件负有信息披露职责的 机构及相关人员。 第三条 公司证券事务中心是负责公司信息披露事务的常设机构，即信息披露事务 管理部门。公司所有信息披露文件、资料以及董事、 ...

海通证券股份有限公司关于中仑新材料股份有限公司 调整部分募集资金投资项目计划进度的核查意见 海通证券股份有限公司（以下简称"海通证券"或"保荐人"）作为中仑新 材料股份有限公司（以下简称"中仑新材"或"公司"）首次公开发行股票并在 创业板上市持续督导保荐人，根据《证券发行上市保荐业务管理办法》《上市公 司监管指引第2号——上市公司募集资金管理和使用的监管要求》《深圳证券交易 所上市公司自律监管指引第13号——保荐业务》《深圳证券交易所创业板股票上 市规则》《深圳证券交易所上市公司自律监管指引第2号——创业板上市公司规范 运作》等有关规定，对公司本次调整部分募集资金投资项目计划进度的事项行了 核查，具体情况如下： 一、募集资金基本情况 经中国证券监督管理委员会《关于同意中仑新材料股份有限公司首次公开发 行股票注册的批复》（证监许可〔2024)112号）同意注册，公司首次向社会公开 发行6,001.0000万股人民币普通股（A股），每股面值为1.00元，每股发行价格为 11.88元，募集资金总额为人民币712,918,800.00元，扣除发行费用78,079,887.24 元（不含增值税）后，募集资金净额为634 ...

中仑新材料股份有限公司 2024 年半年度募集资金存放与使用情况的专项报告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、 误导性陈述或重大遗漏。 根据中国证券监督管理委员会《上市公司监管指引第 2 号——上市公司募集资 金管理和使用的监管要求》《深圳证券交易所上市公司自律监管指引第 2 号——创 业板上市公司规范运作》等监管要求及中仑新材料股份有限公司（以下简称"公司"） 《募集资金管理制度》的规定，公司就 2024 年半年度募集资金存放与使用情况作如 下专项报告： 一、募集资金基本情况 （一）实际募集资金金额、资金到账情况 经中国证券监督管理委员会《关于同意中仑新材料股份有限公司首次公开发行 股票注册的批复》（证监许可[2024]112 号）同意注册，公司首次公开发行人民币普 通股（A 股）股票 6,001 万股，每股发行价格为人民币 11.88 元，募集资金总额为人 民币 712,918,800.00 元，扣除各项发行费用合计人民币 78,079,887.24 元（不含增 值税）后，实际募集资金净额为人民币 634,838,912.76 元。上述募集资金已于 2024 年 6 ...

Financial Performance - The company's operating revenue for the first half of 2024 was approximately ¥1.186 billion, representing a 9.28% increase compared to ¥1.085 billion in the same period last year[13]. - The net profit attributable to shareholders for the same period was approximately ¥100.15 million, a decrease of 14.24% from ¥116.79 million in the previous year[13]. - The net cash flow from operating activities decreased by 18.62% to approximately ¥179.61 million, down from ¥220.72 million in the previous year[13]. - The total assets of the company increased by 28.26% to approximately ¥3.663 billion, compared to ¥2.856 billion at the end of the previous year[13]. - The net assets attributable to shareholders rose by 45.85% to approximately ¥2.333 billion, up from ¥1.600 billion at the end of the previous year[13]. - The basic earnings per share decreased by 14.71% to ¥0.29, down from ¥0.34 in the same period last year[13]. - The diluted earnings per share also decreased by 14.71% to ¥0.29, compared to ¥0.34 in the previous year[13]. - The weighted average return on equity was 6.07%, down from 8.04% in the previous year, reflecting a decrease of 1.97%[13]. Cash Flow and Financing - The company reported a significant increase in cash flow from financing activities, amounting to ¥487,146,281.10, a 529.76% increase due to the initial public offering[36]. - The net increase in cash and cash equivalents was ¥600,548,600.54, a 1,369.43% increase, primarily due to funds raised from the IPO[36]. - The company reported a net cash inflow from financing activities of CNY 487.15 million, compared to a net outflow of CNY 113.35 million in the same period last year[134]. - The cash and cash equivalents at the end of the period increased to CNY 839.94 million, up from CNY 350.15 million at the end of the previous year, marking an increase of approximately 139.80%[134]. Market Position and Products - The company focuses on the research, production, and sales of functional BOPA films, biodegradable BOPLA films, and polyamide 6 (PA6) materials[20]. - Global demand for BOPA films increased from 271,300 tons in 2016 to 381,600 tons in 2020, with a compound annual growth rate (CAGR) of 8.91%[21]. - The company holds a 20% global market share and a 36% domestic market share in the functional BOPA film sector from 2021 to 2023[21]. - The company has successfully industrialized the production of biodegradable BOPLA films, positioning itself as one of the few companies capable of mass production[22]. - The company’s main products are applied in food and beverage, daily chemicals, pharmaceuticals, and soft-pack lithium batteries[24]. - The company has expanded its product offerings to include new types of films such as PHA lithium battery films and EHA fresh-keeping films, targeting high-end food and medical applications[29]. Research and Development - The company has established a comprehensive R&D system, focusing on market-driven innovation and the development of new functional film materials[27]. - Research and development expenses rose by 8.01% to ¥34,304,237.67, reflecting the company's commitment to innovation[36]. - The company has established strategic partnerships with top universities and enterprises, enhancing its research and development capabilities[32]. - The company emphasizes the importance of technological innovation in response to increasing consumer demand for customized and high-end products, highlighting the risks of failing to keep up with industry trends[59]. Environmental and Social Responsibility - The company’s subsidiary, Zhonglun Plastic, is classified as a key pollutant discharge unit and complies with various environmental protection laws and standards[66]. - The company reported no instances of exceeding pollution discharge limits for wastewater and air emissions during the reporting period[67]. - The company implemented energy-saving technical reforms resulting in a total energy savings of 3,950.857 tons of coal equivalent per year, translating to a cost saving of CNY 411.28 million[71]. - The company has actively participated in social welfare activities, including educational donations and pandemic relief efforts[76]. Shareholder and Governance - The company has established a comprehensive corporate governance structure to ensure fair and transparent treatment of all shareholders and timely information disclosure[72]. - The company maintains a strong shareholder structure, with the largest shareholder, Zhonglun Technology Group Co., Ltd., holding 52.27% of the voting rights[112]. - The company has not undergone any changes in its controlling shareholder or actual controller during the reporting period[116]. - The financial report was approved by the board of directors on August 26, 2024[147]. Risks and Challenges - The company faces risks from raw material price fluctuations, particularly due to reliance on caprolactam, which is affected by international crude oil prices[56]. - The company is exposed to exchange rate risks as its BOPA film sales are primarily settled in USD, impacting profitability[57]. - The company acknowledges the risk of talent loss in its R&D team, which is crucial for product innovation and process upgrades, and aims to improve its talent recruitment and training systems[60]. Future Outlook - The company plans to continue expanding its market presence and investing in new technologies[138]. - The company has projected a revenue growth of 20% for the second half of 2024, driven by new product launches and market expansion strategies[165]. - A new market expansion strategy has been implemented, targeting Southeast Asia, which is projected to increase market share by 5%[165].